Gambaran Komplikasi Penyakit Ginjal Kronik Non Dialisis di Poliklinik Ginjal-Hipertensi RSUP Prof. Dr. R. D. Kandou Periode Januari 2017 – Desember 2018

Abstract

Chronic kidney disease (CKD) is still a global health problem with a rising prevalence in many countries. Complications of CKD are inter alia cardiovascular disease, hypertension, anemia, electrolyte disturbance, diabetes mellitus, and metabolic asidosis. This study was aimed to provide an overview of CKD at the Kidney-Hypertension polyclinic of Prof. Dr. R. D. Kandou Hospital. This was a descriptive retrospective study using data of CKD patients at the Kidney-Hypertension Polyclinic from January 2017 to December 2018. The results obtained 63 CKD patients consisting of 47.61% males and 52.38% females. Based on CKD staging, the eprcentages of patients were, as follows: stage 3 CKD (1.58%), stage 4 CKD (22.22%), and stage 5 CKD ND (76.19%). Patients aged 50-59 years had the highest percentage of stage 5 ND CKD numbering 10 males (20.83%) and 12 females (25%). The prevalences of complications in stage 5 ND CKD compared to stage 4 CKD were, as follows: anemia Hb 11-11.9 g/dL (77.5% vs 36.36%), uncontrolled hypertension (37.50% vs 14.28%), dyslipidemia (25% vs 28.57%), hyperurisemia (27.08% in males and 41.67% in females vs 57.15% in males and 28.57% in females), hyponatremia (66.67% vs 64.28%), hypernatremia (31.25% vs 0%), and hypokalemia (16.67% vs 35.72%). In conclusion, CKD complications were anemia, hypertension, dyslipidemia, hyper-urisemia, and electrolite imbalance; most were higher in stadium 5 ND CKD.Keywords: chronic kidney disease, complications Abstrak: Penyakit ginjal kronik (PGK) masih menjadi masalah kesehatan global dan prevalensinya terus meningkat di berbagai negara. Komplikasi PGK antara lain penyakit kardiovaskular, hipertensi, anemia, gangguan elektrolit, diabetes melitus, dan asidosis metabolik. Penelitian ini bertujuan untuk mengetahui gambaran komplikasi PGK di Poliklinik Ginjal-Hipertensi RSUP Prof. Dr. R. D. Kandou. Jenis penelitian ialah deskriptif retrospektif dengan menggunakan data pasien PGK yang dirawat di Poliklinik Ginjal-Hipertensi periode Januari 2017 - Desember 2018. Hasil penelitian mendapatkan 63 pasien PGK, terdiri dari 52,38% perempuan dan 47,61% laki-laki. Berdasarkan stadium PGK, PGK stadium 3 (1,58%) orang, PGK stadium 4 (22,22%), dan PGK stadium 5 ND (76,19%). Kelompok usia tertinggi ialah 50-59 tahun. Prevalensi komplikasi pada PGK stadium 5 ND dibandingkan PGK stadium 4 ialah sebagai berikut: anemia Hb 11-11,9 g/dL (77,5% vs 36,36%), hipertensi tidak terkontrol (37,50% vs 14,28%), dislipidemia (25% vs 28,57%), hiperurisemia (27,08% pada laki-laki dan 41,67% pada perempuan vs 57,15% pada laki-laki dan 28,57% pada perempuan), gangguan elektrolit hiponatremia (66,67% vs 64,28%), hipernatremia (31,25% vs 0%), dan hipokalemia (16,67% vs 35,72%). Simpulan penelitian ini ialah komplikasi PGK ialah anemia, hipertensi, dislipidemia, hiperurisemia, dan gangguan elektrolit; sebagian besar lebih banyak terjadi pada PGK stadium 5 ND.Kata kunci: penyakit ginjal kronik, komplikasi

Hasil Pengukuran Kadar Asam Urat Menggunakan Point of Care Testing (POCT) dan Gold Standard (Chemistry Analyzer)

“…Terdapat juga kelebihan dari POCT yaitu dapat dilakukan secara langsung dengan menggunakan sampel darah yang sedikit, alat lebih kecil atau tidak perlu ruangan khusus sehingga alat mudah dibawa kemanamana. Selain itu, pemeriksaannya dapat dilakukan diluar laboratorium dengan mendapatkan hasil yang cepat misalnya untuk pemeriksaan asam urat (Karinda et al, 2019).…”

Probiotics Delay the Decrease of Kidney Function in Patients with Chronic Kidney Disease

“…CKD results in functional renal problems and a lower glomerular filtration rate (GFR) (less than 60 mL/minute/1.73 m 2 ) (Webster et al, 2017). It is a clinical anomaly or kidney senility disease that reveals a disproportionate arrangement of chemicals in the urine or blood and the presence or absence of blockages based on imaging data (Karinda et al, 2019) CKD affected about 10% of the world's population and was the sixteenth top cause of mortality in 2017 (NKF, 2023) ; (Roth et al, 2018). According to RISKESDAS statistics (2018), the prevalence of CKD is 3.8 ‰ in Indonesia.…”

“…CKD can lead to various consequences if not treated effectively. Cardiovascular and metabolic diseases are among the CKD consequences (Karinda et al, 2019).…”